Development and validation of human psoriatic skin equivalents

American Journal of Pathology

Volumn 173, Issue 3, 2008, Pages 815-823

  Tjabringa, Geuranne ^a,d   Bergers, Mieke ^a   Van Rens, Desiree ^a,b   De Boer, Roelie ^a   Lamme, Evert ^a,c   Schalkwijk, Joost ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Nobilon International BV   (Netherlands)

^c MERCK SERONO S A   (Switzerland)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; CYCLOSPORIN A; CYTOKERATIN 16; CYTOKINE; ELAFIN; EPIDERMAL GROWTH FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 22; INTERLEUKIN 6; INTERLEUKIN 8; KERATINOCYTE GROWTH FACTOR; MESSENGER RNA; RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AIR; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE MODEL; EPIDERMIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PREPUCE; PRIORITY JOURNAL; PSORIASIS; SKIN; TISSUE ENGINEERING; VALIDATION PROCESS;

EID: 51349083691     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.080173     Document Type: Article

References (42)

1. Bowcock AM, Krueger JG: Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 2005, 5:699-711
2. Nair RP, Stuart PE, Nistor I, Hiremagalore R, Chia NV, Jenisch S, Weichenthal M, Abecasis GR, Lim HW, Christophers E, Voorhees JJ, Elder JT: Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 2006, 78:827-851
3. Hollox EJ, Huffmeier U, Zeeuwen PL, Palla R, Lascorz J, Rodijk-Olthuis D, van de Kerkhof PC, Traupe H, de Jongh G, Heijer MD, Reis A, Armour JA, Schalkwijk J: Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 2008, 40:23-25
4. Schön MP, Boehncke WH: Psoriasis. N Engl J Med 2005, 352:1899-1912
5. de Jongh GJ, Zeeuwen PL, Kucharekova M, Pfundt R, van der Valk PG, Blokx W, Dogan A, Hiemstra PS, van de Kerkhof PC, Schalkwijk J: High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 2005, 125:1163-1173
6. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ: The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993, 101:701-705
7. Ettehadi P, Greaves MW, Wallach D, Aderka D, Camp RD: Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin Exp Immunol 1994, 96:146-151
8. Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb AB: Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 1989, 86:6367-6371
9. Bonifati C, Ameglio F: Cytokines in psoriasis. Int J Dermatol 1999, 38:241-251
10. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R: IL-22 increases the innate immunity of tissues. Immunity 2004, 21:241-254
11. Lowes MA, Bowcock AM, Krueger JG: Pathogenesis and therapy of psoriasis. Nature 2007, 445:866-873
12. Gottlieb AB: Psoriasis: emerging therapeutic strategies. Nat Rev Drug Discov 2005, 4:19-34
13. Krueger G, Ellis CN: Psoriasis - recent advances in understanding its pathogenesis and treatment. J Am Acad Dermatol 2005, 53:S94-S100
14. Pol A, Bergers M, Van Ruissen F, Pfundt R, Schalkwijk J: A simple technique for high-throughput screening of drugs that modulate normal and psoriasis-like differentiation in cultured human keratinocytes. Skin Pharmacol Appl Skin Physiol 2002, 15:252-261
15. Pol A, Bergers M, Schalkwijk J: Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assay. In Vitro Cell Dev Biol Anim 2003, 39:36-42
16. Amigó M, Schalkwijk J, Olthuis D, De Rosa S, Paya M, Terencio MC, Lamme E: Identification of avarol derivatives as potential antipsoriatic drugs using an in vitro model for keratinocyte growth and differentiation. Life Sci 2006, 79:2395-2404
17. MacNeil S: Progress and opportunities for tissue-engineered skin. Nature 2007, 445:874-880
18. Netzlaff F, Lehr CM, Wertz PW, Schaefer UF: The human epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Eur J Pharm Biopharm 2005, 60:167-178
19. el-Ghalbzouri A, Gibbs S, Lamme E, Van Blitterswijk CA, Ponec M: Effect of fibroblasts on epidermal regeneration. Br J Dermatol 2002, 147:230-243
20. Barker CL, McHale MT, Gillies AK, Waller J, Pearce DM, Osborne J, Hutchinson PE, Smith GM, Pringle JH: The development and characterization of an in vitro model of psoriasis. J Invest Dermatol 2004, 123:892-901
21. Harrison CA, Layton CM, Hau Z, Bullock AJ, Johnson TS, Macneil S: Transglutaminase inhibitors induce hyperproliferation and parakeratosis in tissue-engineered skin. Br J Dermatol 2007, 156:247-257
22. Engelhart K, El Hindi T, Biesalski HK, Pfitzner I: In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models. Arch Dermatol Res 2005, 297:1-9
23. Zeeuwen PL, van Vlijmen-Willems IM, Jansen BJ, Sotiropoulou G, Curfs JH, Meis JF, Janssen JJ, Van Ruissen F, Schalkwijk J: Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: a new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase. J Invest Dermatol 2001, 116:693-701
24. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408
25. Wingens M, van Bergen BH, Hiemstra PS, Meis JF, van Vlijmen-Willems IM, Zeeuwen PL, Mulder J, Kramps HA, Van Ruissen F, Schalkwijk J: Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes. J Invest Dermatol 1998, 111:996-1002
26. Eaglstein WH, Falanga V: Tissue engineering and the development of Apligraf, a human skin equivalent. Clin Ther 1997, 19:894-905
27. Van Ruissen F, de Jongh GJ, Zeeuwen PL, Van Erp PE, Madsen P, Schalkwijk J: Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures. J Cell Physiol 1996, 168:442-452
28. van Ruissen F, Van Erp PE, de Jongh GJ, Boezeman JB, van de Kerkhof PC, Schalkwijk J: Cell kinetic characterization of growth arrest in cultured human keratinocytes. J Cell Sci 1994, 107:2219-2228
29. Maas-Szabowski N, Stark HJ, Fusenig NE: Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J Invest Dermatol 2000, 114:1075-1084
30. Maas-Szabowski N, Szabowski A, Stark HJ, Andrecht S, Kolbus A, Schorpp-Kistner M, Angel P, Fusenig NE: Organotypic cocultures with genetically modified mouse fibroblasts as a tool to dissect molecular mechanisms regulating keratinocyte growth and differentiation. J Invest Dermatol 2001, 116:816-820
31. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002, 347:1151-1160
32. Erdag G, Morgan JR: Interleukin-1alpha and interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts. Ann Surg 2002, 235:113-124
33. Harder J, Meyer-Hoffert U, Wehkamp K, Schwichtenberg L, Schroder JM: Differential gene induction of human beta-defensins (hBD-1, -2, -3, and -4) in keratinocytes is inhibited by retinoic acid. J Invest Dermatol 2004, 123:522-529
34. Ma HL, Liang S, Li J, Napierata L, Brown T, Benoit S, Senices M, Gill D, Dunussi-Joannopoulos K, Collins M, Nickerson-Nutter C, Fouser LA, Young DA: IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 2008, 118:597-607
35. Boniface K, Diveu C, Morel F, Pedretti N, Froger J, Ravon E, Garcia M, Venereau E, Preisser L, Guignouard E, Guillet G, Dagregorio G, Pene J, Moles JP, Yssel H, Chevalier S, Bernard FX, Gascan H, Lecron JC: Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation. J Immunol 2007, 178:4615-4622
36. Sa SM, Valdez PA, Wu J, Jung K, Zhong F, Hall L, Kasman I, Winer J, Modrusan Z, Danilenko DM, Ouyang W: The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol 2007, 178:2229-2240
37. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, Ouyang W: Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007, 445:648-651
38. Stark HJ, Boehnke K, Mirancea N, Willhauck MJ, Pavesio A, Fusenig NE, Boukamp P: Epidermal homeostasis in long-term scaffold-enforced skin equivalents. J Investig Dermatol Symp Proc 2006, 11:93-105
39. Fuchs E, Green H: Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. Cell 1981, 25:617-625
40. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C: 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992, 68:397-406
41. Breitkreutz D, Stark HJ, Plein P, Baur M, Fusenig NE: Differential modulation of epidermal keratinization in immortalized (HaCaT) and tumorigenic human skin keratinocytes (HaCaT-ras) by retinoic acid and extracellular Ca2+. Differentiation 1993, 54:201-217
42. Nagpal S, Thacher SM, Patel S, Friant S, Malhotra M, Shafer J, Krasinski G, Asano AT, Teng M, Duvic M, Chandraratna RA: Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis. Cell Growth Differ 1996, 7:1783-1791